Skip to main content
GeneDx Holdings Corp. logo

GeneDx Holdings Corp. — Investor Relations & Filings

Ticker · WGS ISIN · US81663L1199 US Human health and social work activities
Open in API
Filings indexed 689 across all filing types
Latest filing 2026-03-17 Director's Dealing
Country US United States of America
Listing US WGS

About GeneDx Holdings Corp.

https://sema4.com/

GeneDx Holdings Corp. is a genomics company specializing in genetic testing services. The company focuses on providing diagnostics for pediatric and rare diseases through expertise in genome and exome sequencing. By leveraging an extensive and diverse rare disease data set, GeneDx delivers personalized health insights intended to inform diagnoses, direct medical treatment, and contribute to drug discovery. The company aims to provide accurate, actionable, and accessible genomic information to help clinicians find answers for patients and their families.

Recent filings

Filing Released Lang Actions
4 - GeneDx Holdings Corp. (0001818331) (Issuer)
Director's Dealing
2026-03-17 English
4 - GeneDx Holdings Corp. (0001818331) (Issuer)
Director's Dealing
2026-03-17 English
4 - GENEDX HOLDINGS CORP. (0001818331) (Filer)
Director's Dealing
2026-03-03 English
8-K - GENEDX HOLDINGS CORP. (0001818331) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by GeneDx Holdings Corp. It details the entry into a material definitive agreement, specifically a $100 million term loan agreement with Blackstone entities. The report includes terms of the loan, interest rates, covenants, and references to the termination of a prior credit agreement. It does not contain full financial statements or comprehensive financial performance data. Instead, it is an update on financing activities and capital structure changes. The document length is 9337 characters, which is substantive but the content is focused on financing arrangements rather than a full financial report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2026-03-02 English
S-8 - GeneDx Holdings Corp. (0001818331) (Filer)
Share Issue/Capital Change Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by GeneDx Holdings Corp. It registers additional shares under the company's equity incentive and employee stock purchase plans. The document includes legal and procedural information about the registration of shares, references prior registration statements, and contains no financial statements or earnings data. Form S-8 is a registration statement for securities to be offered to employees and is related to share issuance and capital changes. Therefore, this filing is best classified as a Share Issue/Capital Change announcement rather than a financial report or other filing type.
2026-02-23 English
10-K - GeneDx Holdings Corp. (0001818331) (Filer)
Annual Report FY 2025
2026-02-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.